bf/NASDAQ:BRZE_icon.png

COM:BRAZE

Braze

  • Stock

USD

Last Close

37.98

22/11 21:00

Market Cap

3.84B

Beta: -

Volume Today

851.62K

Avg: -

Company Overview

Metric
Company NameBraze, Inc.Genesignal
SymbolBRZE
MSH IDCOM:BRAZECOM:GENESIGNAL
MarketSTOCKSPRIVATE
SectorTechnologyHealthcare & Health Services
IndustrySoftware - ApplicationHealthcare
CountryUSGB
StageSeed
Employee Count1.55K
Websitebraze.comgenesignal.com
LinkedInbrazegene-signal
Founders

Market Metrics

Metric
Market Cap3.84B
Enterprise Value
Monthly Web Traffic1.52K
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue471.80M
Revenue (LTM)
Revenue (NTM)
Gross Profit324.27M
EBITDA-144.69M
Operating Income-144.69M
Net Income-129.17M
EPS-1.32
Diluted EPS-1.32
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.69
Operating Profit Margin-0.25
EBITDA Margin-0.31
Net Profit Margin-0.22
Return on Equity-0.27
Return on Assets-0.14
Return on Capital Employed-0.25

Valuation Multiples

Metric
P/E Ratio-40.11
P/B Ratio12.36
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio11.85
EV Multiple-24.48

Operational Metrics

Metric
Days Sales Outstanding59.24
Days Payables Outstanding15.73
Days Inventory Outstanding8.92
Operating Cycle75.27
Cash Conversion Cycle59.63
Asset Turnover0.65

Cash Flow Metrics

Metric
Operating Cash Flow6.85M
Free Cash Flow-2.91M
Cash Flow to Debt0.37
Operating Cash Flow/Sales0.06
Free Cash Flow Yield-0.00

Balance Sheet Metrics

Metric
Cash & Equivalents71.60M
Accounts Receivable-14.01M
Inventory
Goodwill28.45M
Debt to Capitalization0.17
Debt to Assets0.12
Current Ratio2.28
Quick Ratio2.17

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.21
R&D to Revenue0.26
SG&A to Revenue0.25